Annual report [Section 13 and 15(d), not S-K Item 405]

Share Capital (Details)

v3.26.1
Share Capital (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 24, 2024
Share Capital [Line Items]      
Authorized shares 300,000,000    
Shares issued   2,155,172  
Total proceeds (in Dollars)   $ 2,411,027  
Net of issuance cost (in Dollars)   $ 106,768  
Exercise of warrants   240,490  
Exercise of warrants   240,490  
Exercise price per share (in Dollars per share)   $ 4 $ 4
Total proceeds from warrants (in Dollars)   $ 885,003  
Percentage of common shares issued and outstanding 15.00%    
Share-based compensation (in Dollars) $ 430,428 $ 160,865  
Unvested stock options (in Dollars) $ 193,285    
Contractual term 9 years 2 months 12 days    
Weighted average period for recognizing expense 2 years 3 months    
Grant date fair value of options granted (in Dollars per share) $ 1.56    
Option granted    
Intrinsic value of outstanding options (in Dollars)    
Warrants issued   1,077,586 1,077,586
Warrant [Member]      
Share Capital [Line Items]      
Exercise price per share (in Dollars per share)   $ 3.68  
Senior Notes [Member]      
Share Capital [Line Items]      
Price per share (in Dollars per share)   $ 1.16  
Common Stock [Member]      
Share Capital [Line Items]      
Authorized shares 200,000,000    
Shares issued   2,155,172  
Total proceeds (in Dollars)    
Exercise of warrants   240,490  
Common Stock [Member] | Senior Notes [Member]      
Share Capital [Line Items]      
Total proceeds (in Dollars)   $ 2,500,000  
Preferred Stock [Member]      
Share Capital [Line Items]      
Authorized shares 100,000,000